Table 3.
Detailed Subject Information.
| Subject | Gender | Age | Etiology | SRT50a,b | Processor model | Ear | Duration of CI use | Duration of hearing impairment prior to implantation | OLSA in quietb |
|---|---|---|---|---|---|---|---|---|---|
| S1 | F | 57 | Measles at age 4 | 1.6 dB | MEDEL OPUS 2 | L | 10 y | 44 y | 99% |
| R | 14 y | 40 y | 99% | ||||||
| B | 10 y | 99% | |||||||
| S2 | M | 78 | Unknown | 5.1 dB | MEDEL OPUS | L | 9 y | 3 y | 78% |
| R | 4 y | 8 y | 93% | ||||||
| B | 4 y | 89% | |||||||
| S3 | M | 55 | Noise | 2.3 dB | MEDEL OPUS | L | 10 y | 17 y | 98% |
| R | 7 y | 20 y | 94% | ||||||
| B | 7 y | 97% | |||||||
| S4 | F | 38 | Unknown | 1.7 dB | Cochlear CP810 | L | 1 y | 37 y | 75% |
| R | 3 y | 35 y | 84% | ||||||
| B | 1 y | 86% | |||||||
| S5 | M | 34 | LAV | 2.4 dB | AB Harmony | L | 4 y | 30 y | 97% |
| R | 3 y | 31 y | 94% | ||||||
| B | 3 y | 98% | |||||||
| S6 | F | 22 | Unknown | 0.5 dB | Cochlear Freedomc | L | 15 y | 7 y | 91% |
| R | 4 y | 18 y | 84% | ||||||
| B | 4 y | 85% | |||||||
| S7 | M | 20 | Antibiotics at age 3 | −3.4 dB | Cochlear Freedom | L | 7 y | 10 y | 100% |
| R | 6 y | 11 y | 100% | ||||||
| B | 6 y | 99% | |||||||
| S8 | F | 50 | Congenital | 2.6 dB | Cochlear Freedom | L | 8 y | 42 y | 94% |
| R | 5 y | 45 y | 94% | ||||||
| B | 5 y | 99% |
Note. a20 Talker Babble Condition. bHighly reverberant environment. cSubject clinically used Cochlear Freedom on left side, Cochlear CP810 on right side.
For measurements this subject was fitted with two Cochlear Freedom processors (same map, threshold, and maximum comfortable levels as in clinical device).